in the absence of a submission from the holder of the marketing authorisation
dapoxetine hydrochloride (Priligy®) is not recommended for use within NHS Scotland.
Indication under review: treatment of premature ejaculation (PE) in adult men aged 18 to 64 years.
The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication. As a result we cannot recommend its use within NHSScotland.
|Drug Name:||dapoxetine (Priligy)|
|SMC Drug ID:||987/14|
|Manufacturer:||A Menarini Pharmaceuticals UK Ltd|
|Indication:||Treatment of premature ejaculation (PE) in adult men aged 18 to 64 years.|
|Sub Category:||7.4 Drugs for genito-urinary disorders|
|Submission Type:||Non submission|
|Date Advice Published:||7 July 2014|